The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial.
Saved in:
| Title: | The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial. |
|---|---|
| Authors: | Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kim HT; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA., Sainvil MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lange PB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Giardino AA; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA., Bachanova V; Department of Medical Oncology, University of Minnesota, Minneapolis, MN, USA., Devine SM; Department of Medicine, The Ohio State University Comprehensive Cancer Center Ohio State University, Columbus, OH, USA., Waller EK; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Jagirdar N; Department of Hematology/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA., Herrera AF; City of Hope Cancer Center, Duarte, CA, USA., Cutler C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ho VT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Koreth J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Alyea EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McAfee SL; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Chen YB; Bone Marrow Transplant Unit, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA., Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2016 Apr; Vol. 173 (1), pp. 96-104. Date of Electronic Publication: 2016 Jan 05. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2141 |
|---|---|
| DOI: | 10.1111/bjh.13931 |
